| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL
NO PL PT RO RS SE SI SK SM TR |
| (30) |
Priority: |
22.10.2010 US 40576710 P
23.02.2011 US 201161445785 P
|
| (43) |
Date of publication of application: |
|
18.12.2019 Bulletin 2019/51 |
| (62) |
Application number of the earlier application in accordance with Art. 76 EPC: |
|
11835158.4 / 2629801 |
| (73) |
Proprietor: Seagen Inc. |
|
Bothell, WA 98021 (US) |
|
| (72) |
Inventors: |
|
- LEWIS, Timothy S.
Bothell, WA Washington 98021 (US)
- LAW, Che-Leung
Bothell, WA Washington 98021 (US)
- MCEARCHERN, Julie A.
Bothell, WA Washington 98021 (US)
|
| (74) |
Representative: Abel & Imray LLP |
|
Westpoint Building
James Street West
Bath BA1 2DA
Bath BA1 2DA (GB) |
| (56) |
References cited: :
WO-A1-2009/048967
|
WO-A1-2009/117531
|
|
| |
|
|
- MCEARCHERN ET AL.: "Activity of SGN-35 in Preclinical Models of Combination Therapy
and Relapse Prevention", HAEMATOLOGICA, THE HEMATOLOGY JOURNAL, vol. 95, no. S4, 31
October 2010 (2010-10-31), XP002731348, Retrieved from the Internet <URL:http://www.haematologica.org/content/haematol/95/supplement_4/S1.full.pdf>
[retrieved on 20141002]
- CHESON B D: "Novel therapies for peripheral T-cell non-Hodgkin's lymphomas", CURRENT
OPINION IN HEMATOLOGY, RAPID SCIENCE PUBLISHERS, PHILADELPHIA, PA, US, vol. 16, no.
4, 1 July 2009 (2009-07-01), pages 299 - 305, XP008172491, ISSN: 1065-6251, DOI: 10.1097/MOH.0B013E32832AD69A
- PATRICK B. JOHNSTON ET AL: "A Phase II trial of the oral mTOR inhibitor everolimus
in relapsed Hodgkin lymphoma", AMERICAN JOURNAL OF HEMATOLOGY, vol. 85, no. 5, 1 January
2010 (2010-01-01), pages NA - NA, XP055123462, ISSN: 0361-8609, DOI: 10.1002/ajh.21664
- YOUNES ET AL: "Multiple complete responses in a phase 1 dose-escalation study of the
antibody- drug conjugate SGN-35 in patients with relapsed or refractory CD30-positive
lymphomas", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 112, no. 11, 1 January
2008 (2008-01-01), pages 1006, XP008170898, ISSN: 0006-4971
- JONA A ET AL: "Novel treatment strategies for patients with relapsed classical Hodgkin
lymphoma", BLOOD REVIEWS, CHURCHILL LIVINGSTONE, AMSTERDAM, NL, vol. 24, no. 6, 15
September 2010 (2010-09-15), pages 233 - 238, XP027471337, ISSN: 0268-960X, [retrieved
on 20101101], DOI: 10.1016/J.BLRE.2010.08.003
- T.S. LEWIS ET AL.: "Auristatin-based antibody-drug conjugates are synergistic in combination
with PI3K-AKT-mTOR pathway inhibitors in hematologic malignancies and carcinoma",
CANCER RESEARCH, vol. 71, no. S1, 15 April 2011 (2011-04-15), XP002731350, Retrieved
from the Internet <URL:http://cancerres.aacrjournals.org/cgi/content/short/71/8_MeetingAbstracts/1789>
[retrieved on 20141001]
|
|
